Antibodies Reactive to Leptin in Adults with Type 2 Diabetes and Its Relationship with Clinical, Metabolic and Cardiovascular Risk Parameters

References

• International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: 2021: https://www.diabetesatlas.org
   Google Scholar
• Basto-Abreu AC, López-Olmedo N, Rojas-Martínez R, et al. Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020. Salud Publica Mex. 2021 5;63(6):725–733. doi:10.21149/12842.
   PubMed Web of Science ®Google Scholar
• OECD. Health at a Glance 2021: OECD Indicators. OECD; 2021. doi:10.1787/ae3016b9-en.
   Google Scholar
• Ruze R, Liu T, Zou X, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol. 2023;14:1161521. doi:10.3389/fendo.2023.1161521.
   PubMed Web of Science ®Google Scholar
• Massey W, Brown JM. The gut microbial endocrine organ in type 2 diabetes. Endocrinology. 2021;162(2):1–14. doi:10.1210/endocr/bqaa235.
   Web of Science ®Google Scholar
• Martínez-Sánchez N. There and back again: leptin actions in white adipose tissue. IJMS. 2020;21(17):6039. doi:10.3390/ijms21176039.
   Google Scholar
• Liu J, Lai F, Hou Y, Zheng R. Leptin signalling and leptin resistance. Medical Review. 2022;2(4):363–384. doi:10.1515/mr-2022-0017.
   Google Scholar
• Fetissov SO, Hamze Sinno M, Coëffier M, et al. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition. 2008;24(4):348–359. doi:10.1016/j.nut.2007.12.006.
   PubMed Web of Science ®Google Scholar
• Fetissov SO, Hamze Sinno M, Coquerel Q, et al. Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition. 2008;24(9):854–859. doi:10.1016/j.nut.2008.06.021.
   PubMed Web of Science ®Google Scholar
• Bouhajja H, Bougacha-Elleuch N, Lucas N, et al. Affinity kinetics of leptin-reactive immunoglobulins are associated with plasma leptin and markers of obesity and diabetes. Nutr & Diabetes. 2018;8(1):32. doi:10.1038/s41387-018-0044-y.
   PubMedGoogle Scholar
• Vázquez-Solórzano R, Valdés-Miramontes E, Porchas-Quijada M, et al. Leptin-reactive antibodies are distinctly correlated with body composition parameters and metabolic risk indexes in children and adolescents. Clin Exp Immunol. 2022;208(2):233–244. doi:10.1093/cei/uxab001.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(1):S17–S38. doi:10.2337/dc22-S002.
   PubMedGoogle Scholar
• World Health Organization, WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1–253.
   Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. doi:10.1093/clinchem/18.6.499.
   PubMed Web of Science ®Google Scholar
• Frohlich J, Dobiášová M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-Cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003;49(11):1873–1880. doi:10.1373/clinchem.2003.022558.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883.
   PubMed Web of Science ®Google Scholar
• Qu HQ, Li Q, Rentfro AR, Fisher-Hoch SP, McCormick JB. The definition of insulin resistance using HOMA-IR for americans of Mexican descent using machine learning. Vella A, ed. PLoS One. 2011;6(6):e21041. doi:10.1371/journal.pone.0021041.
   PubMed Web of Science ®Google Scholar
• Porchas-Quijada M, Reyes-Castillo Z, Muñoz-Valle JF, et al. IgG anti-ghrelin immune complexes are increased in rheumatoid arthritis patients under biologic therapy and are related to clinical and metabolic markers. Front Endocrinol. 2019;10:252. doi:10.3389/fendo.2019.00252.
   PubMed Web of Science ®Google Scholar
• Fetissov SO. Neuropeptide Autoantibodies Assay. In: Merighi A, eds. Neuropeptides. Vol. 789. Methods in Molecular Biology, Humana Press; 2011:pp. 295–302. 10.1007/978-1-61779-310-3_19.
   Google Scholar
• Sáinz N, Barrenetxe J, Moreno-Aliaga MJ, Martínez JA. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metabolism. 2015;64(1):35–46. doi:10.1016/j.metabol.2014.10.015.
   PubMed Web of Science ®Google Scholar
• Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O. Leptin resistance: underlying mechanisms and diagnosis. DMSO. 2019;12:191–198. doi:10.2147/DMSO.S182406.
   Google Scholar
• Liu J, Yang X, Yu S, Zheng R. The leptin resistance. In: Wu Q Zheng R, eds. Neural Regulation of Metabolism. Vol. 1090. Springer Singapore; 2018:pp. 145–163. 10.1007/978-981-13-1286-1_8.
   Google Scholar
• Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis: obesity and CRP in various populations J. Choi et al. Obes Rev. 2013;14(3):232–244. doi:10.1111/obr.12003.
   PubMed Web of Science ®Google Scholar
• Rojas M, Restrepo-Jiménez P, Monsalve DM, et al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95:100–123. doi:10.1016/j.jaut.2018.10.012.
   PubMed Web of Science ®Google Scholar
• Salgaço MK, Oliveira LGS, Costa GN, Bianchi F, Sivieri K. Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus. Appl Microbiol Biotechnol. 2019;103(23–24):9229–9238. doi:10.1007/s00253-019-10156-y.
   PubMed Web of Science ®Google Scholar
• Larsen N, Vogensen FK, van den Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. Bereswill S, ed. PLoS One. 2010;5(2):e9085. doi:10.1371/journal.pone.0009085.
   PubMed Web of Science ®Google Scholar
• Le Bastard Q, Al-Ghalith GA, Grégoire M, et al. Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications. Aliment Pharmacol Ther. 2018;47(3):332–345. doi:10.1111/apt.14451.
   PubMed Web of Science ®Google Scholar
• Harris RBS. Direct and indirect effects of leptin on adipocyte metabolism. Biochimica Et Biophysica Acta (BBA) - Molecular Basis Of Disease. 2014;1842(3):414–423. doi:10.1016/j.bbadis.2013.05.009.
   PubMed Web of Science ®Google Scholar
• Hackl MT, Fürnsinn C, Schuh CM, et al. Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis. Nat Commun. 2019;10(1):2717. doi:10.1038/s41467-019-10684-1.
   PubMedGoogle Scholar
• Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: a brief review. Curr Diab Rep. 2018;18(12):127. doi:10.1007/s11892-018-1101-6.
   PubMed Web of Science ®Google Scholar
• Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care. 2000;23(11):1679–1685. doi:10.2337/diacare.23.11.1679.
   PubMed Web of Science ®Google Scholar
• Meek TH, Morton GJ. The role of leptin in diabetes: metabolic effects. Diabetologia. 2016;59(5):928–932. doi:10.1007/s00125-016-3898-3.
   PubMed Web of Science ®Google Scholar
• La Cava A. Leptin in inflammation and autoimmunity. Cytokine. 2017;98:51–58. doi:10.1016/j.cyto.2016.10.011.
   PubMed Web of Science ®Google Scholar
• Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future. DD&T. 2015;9(6):380–385. doi:10.5582/ddt.2015.01207.
   PubMed Web of Science ®Google Scholar
• Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm. 2014 Jun;5(3):79–83. doi:10.4103/0976-0105.139731.
   PubMedGoogle Scholar